Healthcare provider profile · identity verified

April Ann Nutt, APRN

Nurse Practitioner · CARAWAY, AR · NPI 1508533050

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Pantoprazole Sodium	Pantoprazole Sodium	231	48
Furosemide	Furosemide	204	34
Potassium Chloride	Potassium Chloride	196	36
Atorvastatin Calcium	Atorvastatin Calcium	195	36
Sertraline Hcl	Sertraline Hcl	174	30
Trazodone Hcl	Trazodone Hcl	138	26
Montelukast Sodium	Montelukast Sodium	137	22
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	134	51
Levothyroxine Sodium	Levothyroxine Sodium	133	24
Gabapentin	Gabapentin	130	29
Eliquis	Apixaban	129	17
Lisinopril	Lisinopril	113	21
Mirtazapine	Mirtazapine	113	23
Metoprolol Tartrate	Metoprolol Tartrate	97	14
Buspirone Hcl	Buspirone Hcl	86	15
Metformin Hcl	Metformin Hcl	86	16
Lorazepam	Lorazepam	85	34
Fluticasone Propionate	Fluticasone Propionate	76	26
Tamsulosin Hcl	Tamsulosin Hcl	66	13
Divalproex Sodium	Divalproex Sodium	65	11
Clopidogrel	Clopidogrel Bisulfate	63	11
Donepezil Hcl	Donepezil Hcl	56	13
Duloxetine Hcl	Duloxetine Hcl	56	11
Hydrochlorothiazide	Hydrochlorothiazide	55	suppressed
Jardiance	Empagliflozin	55	suppressed
Tramadol Hcl	Tramadol Hcl	49	25
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	48	suppressed
Sucralfate	Sucralfate	48	suppressed
Amlodipine Besylate	Amlodipine Besylate	47	12
Spironolactone	Spironolactone	47	suppressed
Levetiracetam	Levetiracetam	45	suppressed
Losartan Potassium	Losartan Potassium	44	suppressed
Metoprolol Succinate	Metoprolol Succinate	43	11
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	41	25
Citalopram Hbr	Citalopram Hydrobromide	40	suppressed
Lactulose	Lactulose	40	suppressed
Alprazolam	Alprazolam	39	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	38	33
Amiodarone Hcl	Amiodarone Hcl	37	suppressed
Lidocaine Hcl	Lidocaine Hcl	37	28
Megestrol Acetate	Megestrol Acetate	37	18
Pregabalin	Pregabalin	35	suppressed
Glipizide	Glipizide	34	suppressed
Memantine Hcl	Memantine Hcl	34	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	34	12
Azithromycin	Azithromycin	33	26
Fluconazole	Fluconazole	33	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	33	suppressed
Simvastatin	Simvastatin	33	suppressed
Finasteride	Finasteride	32	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	suppressed
Novolog Flexpen	Insulin Aspart	29	suppressed
Farxiga	Dapagliflozin Propanediol	28	suppressed
Xarelto	Rivaroxaban	28	suppressed
Ceftriaxone	Ceftriaxone Sodium	27	21
Hydralazine Hcl	Hydralazine Hcl	26	suppressed
Novolin N Flexpen	Insulin Nph Human Isophane	26	suppressed
Diltiazem Hcl	Diltiazem Hcl	25	suppressed
Ondansetron Hcl	Ondansetron Hcl	25	20
Ondansetron Odt	Ondansetron	25	14
Albuterol Sulfate Hfa	Albuterol Sulfate	24	16
Allopurinol	Allopurinol	24	suppressed
Carvedilol	Carvedilol	24	suppressed
Diazepam	Diazepam	24	suppressed
Fycompa	Perampanel	24	suppressed
Pravastatin Sodium	Pravastatin Sodium	24	suppressed
Briviact	Brivaracetam	23	suppressed
Dexamethasone	Dexamethasone	23	22
Rosuvastatin Calcium	Rosuvastatin Calcium	23	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Myrbetriq	Mirabegron	22	suppressed
Risperidone	Risperidone	22	suppressed
Linzess	Linaclotide	21	suppressed
Phenytoin	Phenytoin	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	13
Clobazam	Clobazam	20	suppressed
Prednisolone Acetate	Prednisolone Acetate	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Bumetanide	Bumetanide	19	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	19	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	18	suppressed
Levofloxacin	Levofloxacin	18	13
Nurtec Odt	Rimegepant Sulfate	18	suppressed
Nystatin	Nystatin	18	suppressed
Olanzapine	Olanzapine	18	suppressed
Tresiba Flextouch U-100	Insulin Degludec	18	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Phenobarbital	Phenobarbital	17	suppressed
Clonazepam	Clonazepam	16	suppressed
Amoxicillin	Amoxicillin	15	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Topiramate	Topiramate	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Digoxin	Digoxin	14	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	suppressed
Bupropion Hcl	Bupropion Hcl	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	12
Ertapenem	Ertapenem Sodium	13	11
Ezetimibe	Ezetimibe	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Metformin Hcl Er	Metformin Hcl	13	suppressed
Valsartan	Valsartan	13	suppressed
Brilinta	Ticagrelor	12	suppressed
Cefdinir	Cefdinir	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Memantine Hcl Er	Memantine Hcl	12	suppressed
Metolazone	Metolazone	12	suppressed
Ramipril	Ramipril	12	suppressed
Unifine Safecontrol Pen Needle	Pen Needle,dual Safety,diabetc	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Primidone	Primidone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error